PPT-Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants

functioning Luis Sagaon Teyssier Yves Arrighi Boniface Dongmo Nguimfack JeanPaul Moatti Aknowledgements This study is part of a project funded by UNITAID and developed by The French National Agency for Research on AIDS and viral Hepatitis . Notwithstanding the provisions of Article I of the General Agreement contracting parties may accord differential and more favourable treatment to developing countries without according such treatment to other contracting parties 2 The provisions of of Competition reforms in socio-economic development in developing countries . . . Pradeep S. Mehta. CUTS Internationa. l. Role . of Competition reforms in socio-economic development in developing countries . Macroeconomic Policies . for Developing Countries. June 19, 2015. Jeffrey Frankel. Harpel Professor of Capital Formation & Growth. 2. Prequel: In 2008, the government of Chilean President . Bachelet. Shaw Vonder Hoya. Worldwide Prevalence. Types of HIV. HIV type 1:. Most common. Originated from chimpanzee SIV. High infectivity and virulence. HIV type 2:. Mostly confined to West Africa. Came from sooty . Greg Perry. Melbourne – International AIDS Conference. July 2014. 1. The Future of HIV Treatment?. All people on treatment have access to the best possible regimens. Treatment side effects are minimal or non-existent. Suzanne Hill . IPC. , December 2015. acknowledgements. Sabine Vogler, GOEG. Swathi . Iyengar. Kiu Tay. Peter Beyer. The story so far….. New direct acting antivirals on the EML:. Sofosbuvir. . simeprevir. Patents, pricing and pharma, Special session » . Pauline Londeix. XX International AIDS conference - AIDS2014 - Melbourne, Australia. Acknowledgments. Special thank to Françoise Barré-Sinoussi & Eric Fleutelot. Dr . Flavia. Senkubuge. Specialist Public Health Medicine. University of Pretoria. 28 February 2011. Introduction. HIV&AIDS remains of Public Health concern in Africa. Significant strides made but much still to be achieved. /. GreganneBremner. /. EricaRoss. What is HIV/Aids. The . Human Immunodeficiency Virus . or. HIV. , is the virus that causes HIV infection. During HIV infection, the virus attacks and destroys the infection-fighting CD4 cells of the body’s immune system. Loss of CD4 cells makes it difficult for the immune system to fight infections. Like all virus HIV is an intracellular parasite; it cannot survive and replicate unless it is inside a living cell. There are two types of HIV infections that has been identified, they are HIV-1 and HIV-2.. Suzanne Hill . IPC. , December 2015. acknowledgements. Sabine Vogler, GOEG. Swathi . Iyengar. Kiu Tay. Peter Beyer. The story so far….. New direct acting antivirals on the EML:. Sofosbuvir. . simeprevir. Public expenditure on drug treatment and associated comorbidities: a case study of Bergamo Sabrina Molinaro, PhD Institute of Clinical Physiology ,National Research Council of Italy (CNR) Lisbon Addiction Conference Interventions to Prevent and Treat HIV Among People Who Inject DrugsAugust 2015HARM REDUCTIONAND THE GLOBAL HIVEPIDEMICTABLE OF CONTENTSEXECUTIVE SUMMARYMETHODOLOGYPWID PREVALENCE AND ACCESS TO PREVEN APM Resident Education Curriculum. Karina . Uldall. MD, MPH . Inpatient Psychiatry and Psychosomatic Medicine . Section Head, Virginia Mason Hospital Psychiatry Consultation Service. Updated. Fall 2013. . . Pradeep S. Mehta. CUTS Internationa. l. Role . of Competition reforms in socio-economic development in developing countries . 1. “Strong competition policy is not just a luxury to be enjoyed by rich countries, but a real necessity for those striving to create democratic market economies”..